# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-321753
Filing Date
2018-11-08
Accepted
2018-11-08 06:19:13
Documents
24
Period of Report
2018-11-08

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 6-K | d651769d6k.htm | 6-K | 38706
2 | GRAPHIC | g651769g66q83.jpg | GRAPHIC | 32389
3 | GRAPHIC | g651769txs10g1.jpg | GRAPHIC | 336468
4 | GRAPHIC | g651769txs11g1.jpg | GRAPHIC | 252580
5 | GRAPHIC | g651769txs12g1.jpg | GRAPHIC | 255561
6 | GRAPHIC | g651769txs13g1.jpg | GRAPHIC | 181147
7 | GRAPHIC | g651769txs14g1.jpg | GRAPHIC | 280816
8 | GRAPHIC | g651769txs15g1.jpg | GRAPHIC | 307273
9 | GRAPHIC | g651769txs16g1.jpg | GRAPHIC | 222953
10 | GRAPHIC | g651769txs17g1.jpg | GRAPHIC | 66348
11 | GRAPHIC | g651769txs18g1.jpg | GRAPHIC | 211357
12 | GRAPHIC | g651769txs19g1.jpg | GRAPHIC | 336609
13 | GRAPHIC | g651769txs20g1.jpg | GRAPHIC | 321906
14 | GRAPHIC | g651769txs21g1.jpg | GRAPHIC | 273304
15 | GRAPHIC | g651769txs22g1.jpg | GRAPHIC | 57104
16 | GRAPHIC | g651769txs23g1.jpg | GRAPHIC | 201423
17 | GRAPHIC | g651769txs24g1.jpg | GRAPHIC | 217630
18 | GRAPHIC | g651769txs25g1.jpg | GRAPHIC | 215576
19 | GRAPHIC | g651769txs26g1.jpg | GRAPHIC | 350993
20 | GRAPHIC | g651769txs27g1.jpg | GRAPHIC | 79878
21 | GRAPHIC | g651769txs6g1.jpg | GRAPHIC | 188122
22 | GRAPHIC | g651769txs7g1.jpg | GRAPHIC | 317994
23 | GRAPHIC | g651769txs8g1.jpg | GRAPHIC | 249155
24 | GRAPHIC | g651769txs9g1.jpg | GRAPHIC | 76005
| Complete submission text file | 0001193125-18-321753.txt |  | 6973688

Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 181168039
SIC: 2834 Pharmaceutical Preparations